Use of Nonsteroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk in the Women's Health Initiative.
Theodore M BraskyLeah R JagerAlison M NewtonXilin LiHolli A Loomans-KroppJohn L HaysKaren L MargolisJuhua LuoPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
This study adds to existing evidence from prospective studies and clinical trials suggesting that use of aspirin may provide moderate benefit for pancreatic cancer prevention.
Keyphrases
- anti inflammatory drugs
- clinical trial
- public health
- healthcare
- low dose
- polycystic ovary syndrome
- mental health
- quality improvement
- high intensity
- cardiovascular events
- health information
- randomized controlled trial
- cardiovascular disease
- antiplatelet therapy
- pregnancy outcomes
- climate change
- study protocol
- case control
- atrial fibrillation
- breast cancer risk